A decreased phosphorylation of EGFR (Tyr1068) and the down-stream Akt (Ser473) pathway was noted in ANXA1 knockdown with Osimertinib treatment H1975 and H1650 lung cancer cells (Figure 4A,B). This evidence concerns the gene EGFR and lung carcinoma.